Join to View Full Profile
2829 Babcock RdSte 300San Antonio, TX 78229
Phone+1 210-580-9500
Fax+1 210-568-4397
Dr. Song is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Song is an internal medicine specialist with subspecialties in hematology and oncology based in San Antonio, TX. He completed his fellowship in Hematology and Medical Oncology at Baylor College of Medicine in 2024 after finishing his residency in Internal Medicine at the University of Texas Health Science Center. He holds a combined MD/PhD in Medicine, Biochemistry, Cellular & Molecular Biology from Texas Tech University Health Sciences Center and earned a PharmD from The University of Texas at Austin College of Pharmacy. Dr. Song is currently a Medical Oncologist, Hematologist, and Clinical Investigator at NEXT Oncology in San Antonio. His research work includes several published studies in cancer treatment, with his publications cited frequently by other researchers.
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2021 - 2024
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2018 - 2021
Texas Tech University Health Sciences Center - Combined MD/PhD ProgramMD, PhD, Medicine, Biochemistry, Cellular & Molecular Biology, 2010 - 2018
Texas Tech University Health Sciences Center School of MedicineClass of 2018- The University of Texas at Austin College of PharmacyPharmD, Pharmacy, 2002
Certifications & Licensure
TX State Medical License 2019 - 2026
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 9 citationsCytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.Michael M. Song, Monish Ram Makena, Ashly Hindle, Balakrishna Koneru, Thinh H. Nguyen
Anti-Cancer Drugs. 2019-02-01 - 7 citationsCorrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.Jo Lynne Harenza, Maura Diamond, Rebecca N. Adams, Michael M. Song, Heather L. Davidson
Scientific Data. 2017-12-05 - 108 citationsTranscriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura Diamond, Rebecca N. Adams, Michael M. Song, Heather L. Davidson
Scientific Data. 2017-03-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
